BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19303779)

  • 1. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
    Khasraw M; Bell D; Wheeler H
    J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; BĂ©langer K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ; Malkin MG; Kleber M; Abrey LE
    Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rechallenge with temozolomide in patients with recurrent gliomas.
    Wick A; Pascher C; Wick W; Jauch T; Weller M; Bogdahn U; Hau P
    J Neurol; 2009 May; 256(5):734-41. PubMed ID: 19240962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
    Parlato C; Barbarisi M; Moraci M; Moraci A
    Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas.
    Corsa P; Parisi S; Raguso A; Troiano M; Perrone A; Cossa S; Munafò T; Piombino M; Spagnoletti G; Borgia F
    Tumori; 2006; 92(4):299-305. PubMed ID: 17036520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide in malignant gliomas: current use and future targets.
    Villano JL; Seery TE; Bressler LR
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide-induced flare in high-grade gliomas: a new clinical entity.
    Rosenthal MA; Ashley DL; Cher L
    Intern Med J; 2002 Jul; 32(7):346-8. PubMed ID: 12088355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
    Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage temozolomide for prior temozolomide responders.
    Franceschi E; Omuro AM; Lassman AB; Demopoulos A; Nolan C; Abrey LE
    Cancer; 2005 Dec; 104(11):2473-6. PubMed ID: 16270316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Temozolomide in the treatment of recurrent malignant glioma].
    Kobayashi H; Sawamura Y; Ishii N; Murata J; Iwasaki Y
    No Shinkei Geka; 2006 Dec; 34(12):1241-7. PubMed ID: 17154070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glioma therapy up-date].
    de la Fuente BP; Dalmau J; Rosenfeld M
    Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.
    Perry JR; Rizek P; Cashman R; Morrison M; Morrison T
    Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
    Zhang JP; Shi HL; Sai K; Yue WY; Mu YG; Zhang XH; Chen ZP
    Ai Zheng; 2006 Dec; 25(12):1533-7. PubMed ID: 17166381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.